MentionFox
Home › Executive changes › Biohaven Ltd.
Leadership changes · SEC Form 8-K, Item 5.02

Biohaven Ltd. executive changes

Every leadership change Biohaven Ltd. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Appointments named2
Departures named1
Latest filing2026-08-07

Biohaven Ltd. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-07. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-08-07 · 8-K

Appointed: John Yetimoglu, Director, effective 2026-08-06

On August 3, 2026, the Board of Directors (the "Board") of Biohaven Ltd. (the "Company") appointed John Yetimoglu as a director, effective August 6, 2026.
Filed 2026-07-09 · 8-K

Departing: Bruce Car, Chief Scientific Officer, effective 2026-07-13

On July 9, 2026, Biohaven Ltd. (the "Company") and Bruce Car, Ph.D., mutually agreed that, effective July 13, 2026, Dr. Car will retire as Chief Scientific Officer of the Company and will remain with the Company as a part-time employee in the newly created role of Chief Innovation Officer.

Appointed: David Pirman, Executive Vice President, effective 2026-07-13

In connection with this transition, David Pirman, Ph.D., has been promoted to Executive Vice President and Head of Discovery, effective July 13, 2026.
Hiring for a seat like this?

Find people with the same kind of experience as the Director at Biohaven Ltd., with the record behind each one.

Find candidates like Director at Biohaven Ltd.
Selling to Biohaven Ltd.?

New leaders review vendors and budgets in their first months. Get an alert the next time Biohaven Ltd. is in the news or changes leadership.

Get an alert when Biohaven Ltd. changes leadership

Tools for this story

Each opens in a new tab, filled in for Biohaven Ltd.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/biohaven
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Biohaven Ltd. (BHVN) executive changes: John Yetimoglu appointed, Director. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/biohaven